Search PubMed⌕ Search

Biomedical subjects

M Jarema

Publications and source records attributed to M Jarema.

79 records · Page 5Linked to original sources
PubMedDate not supplied

[The evaluation of well-being of schizophrenic or depressed patients with Bradley's questionnaire: a pilot study].

Well-being of 65 in-patients with the diagnosis of schizophrenia or major depression was evaluated with the use of Bradley's well-being questionnaire. The severity of psychopathology as well as clinical improvement after pharmacotherapy were evaluated by doctors using CGI scale. Patients with the diagnosis of depression estimated their well-being lower in comparison to schizophrenics. The groups did not differ in the subscales of depression and energy. Female patients revealed more anxiety than male ones, regardless diagnosis. Physicians' evaluation of disease severity did not correlate with patients' well-being judgement using Bradley's questionnaire. After pharmacotherapy correlation between clinical improvement and several questions from Bradley's questionnaire was found.

Adult↗
PubMedDate not supplied

[Evaluation of health-related quality of life in hospitalized schizophrenics].

Health related quality of life was evaluated in 40 schizophrenics from day hospital at admission, during the treatment and after 8 weeks. In contrast to the psychopathology which significantly decreased after 4 weeks already, the improvement of quality of life was found to be significant only at the discharge from day hospital. The quality of life did not correlate with the severity of schizophrenic symptoms. The older and more frequently hospitalized patients were, the less favorably they evaluated the quality of life. Patients professionally disabled were also less pleased with their quality of life. All quality of life domains improved after treatment with the exception of physical functioning and reported health transition. Physical functioning, role-physical, general health and mental health correlated inversely with severity of schizophrenia after treatment. There was no correlation between clinical improvement after treatment and quality of life domains. The higher was the patients' educational level the better they evaluated their vitality, social functioning and reported health transition.

Adult↗
PubMedDate not supplied

[Cortical atrophy in MRI, mental status and neuroleptic treatment effect in schizophrenia].

MR imaging of the head was performed in forty schizophrenics (DSM-IV). Mental status was evaluated before and during 8-weeks of neuroleptic treatment. Cortical atrophy in frontal and temporal regions was found in 40% of subjects. They were older, had longer history of schizophrenia, were less active professionally and were more frequently hospitalized. Patients with and without cortical atrophy in MRI did not differ in the severity of schizophrenic psychopathology at baseline. During neuroleptic treatment negative schizophrenia symptoms were significantly better diminished in patients without cortical atrophy than in subjects with cortical atrophy in MRI; this regarded specially the severity of emotional blunting. Clinical improvement after 8-weeks of neuroleptic administration was less favorable in patients with cortical atrophy.

Adult↗
PubMedDate not supplied

[Comparison of quality of life of schizophrenic patients in different forms of psychiatric care].

Health related quality of life and severity of psychopathological symptoms were evaluated in 90 patients with schizophrenia, hospitalized in a psychiatric ward in a day hospital or followed by the therapist in a community care center. No statistical differences were found in the quality of life evaluation between patients from all three settings. The quality of life did not correlate with the severity of schizophrenic symptoms. Older patients and those more frequently hospitalized were more pessimistic in evaluation of their quality of life. Health status transition, as compared to the situation one year before, correlated inversely with patients' age. Male patients as well as patients from schizophrenic families evaluated their quality of life as worse.

Adult↗
PubMedDate not supplied

[Evaluation of depressive syndromes in the course of schizophrenia with the use of Calgary scale in patients from the inpatient hospital care].

Among 98 schizophrenic patients consecutively admitted to day hospital during the period of one year, the presence of depressive syndrome diagnosed with the use of Calgary Depression Scale was established in 39% of patients. The intensity of depression was higher in the patients' than in the investigators' evaluation. After therapy at day hospital, which lasted 3.7 months on average, the repeated clinical evaluation showed significant decrease of all depressive symptoms as well as schizophrenia psychopathology. In 29% of patients there were no symptoms of depression at discharge from the day hospital. In 66%, the depressive symptoms which were most severe at admission, i.e. depressive mood, hopelessness and guilty ideas of reference, showed most distinct diminution after treatment.

Adolescent↗
PubMedDate not supplied

[Family burden of schizophrenic patients with various forms of psychiatric care].

Caregiver burden was evaluated among family members of 90 schizophrenic patients from hospital psychiatric ward, day hospital or from community psychiatry unit. Psychopathology was evaluated with the use of PANSS while family burden with the use of Tessler's scale which allowed to differentiate between objective and subjective burden regarding assistance to the subject and patient's supervision. Schizophrenic symptoms were more severe in hospitalized patients than among patients from day hospital or patients treated in the community. Family burden, both subjective and objective was more severe among family members of hospitalized patients. There was no difference in the severity of family burden among family members of patients from day-hospital or from community psychiatry unit. The severity of positive and general schizophrenic symptoms (PANSS) correlated positively with the lack of patient's acceptance by a family member as well as with the global subjective family burden and with the necessity of taking control over patient. There was a positive correlation between the severity of schizophrenic negative symptoms and subjective family burden (dimension: assistance to the patient) and the sum of objective family burden.

Adult↗